Powered by OpenAIRE graph
Found an issue? Give us feedback
View all 1 versions

SINTEF, (head-office), Health, Medical Technology

corporate_fareorganization

SINTEF, (head-office), Health, Medical Technology

1 Projects, page 1 of 1

  • NANOSPRESSO-NL: Local preparation of high-quality, personalized nucleic acid nanomedicines

    assignment_turned_inProject2022 - 9999Partners:Saxion, Universitair Medisch Centrum Utrecht, Divisie Laboratoria, Apotheek en Biomedische Genetica, Leiden University, Universiteit Twente, Faculty of Science and Technology (TNW), Fysische Scheidingen, Erasmus Universiteit Rotterdam, Erasmus School of Health Policy & Management ( ESHPM ) +15 partners
    Funder: Netherlands Organisation for Scientific Research (NWO) Project Code: NWA.1389.20.096

    NANOSPRESSO-NL specifically addresses the current mismatch between personalized therapeutic strategies and industrial centralized large-scale manufacture of medicines. The NANOSPRESSO-NL consortium is convinced that nucleic acid therapeutics are uniquely qualified for production in local hospital pharmacies in response to the needs of the individual patient. By switching towards a fully standardised platform formulation, quality control can be centred around the production process rather than the end product, quite similar to a popular method of decentralized high-quality espresso making.

    more_vert

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

Content report
No reports available
Funder report
No option selected
arrow_drop_down

Do you wish to download a CSV file? Note that this process may take a while.

There was an error in csv downloading. Please try again later.